INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.
2024年6月4日，宾夕法尼亚州普利茅斯会议（PRNewswire） - 生物技术公司INOVIO（纳斯达克：INO）专注于开发和推广DNA药物来帮助治疗和预防人类乳头瘤病毒相关疾病，癌症和传染病。今天宣布，INOVIO的总裁兼首席执行官Dr. Jacqueline Shea和首席医学官Dr. Michael Sumner将参加由Stephens，Inc.的业务部主管和权益研究分析师Sudan Loganathan，博士主持的虚拟炉边聊天活动。
The fireside chat will take place on Tuesday, June 11, 2024, at 11:00am ET. This event is only available to institutional clients of Stephens. Please reach out to your Stephens contact for event details.
本次炉边聊天将于2024年6月11日星期二东部时间上午11:00举行。此活动仅向Stephens的机构客户开放。请联系您的Stephens联系人了解活动详情。
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .
关于INOVIO
INOVIO是一家专注于开发和推广DNA药物以帮助治疗和预防人类乳头瘤病毒相关疾病，癌症和传染病的生物技术公司。 INOVIO的技术优化了设计和交付创新的DNA药物，教导人体制造自己的抗疾病工具。欲了解更多信息，请访问。
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Thomas Hong, (267) 440-4298, [email protected]
联系方式
媒体：Jennie Willson，（267）429-8567，[email protected]
投资者：Thomas Hong，（267）440-4298，[email protected]
SOURCE INOVIO Pharmaceuticals, Inc.
消息来源：INOVIO Pharmaceuticals，Inc.